About 8,540,000 results
Open links in new tab
Regor Enters into a Definitive Purchase Agreement for Genentech …
Regor to Sell Breast Cancer CDK Inhibitors to Roche Unit for …
Genentech buys Regor's next-gen CDK inhibitors for $850M
Regor to Sell Portfolio of Breast Cancer Treatment CDK Inhibitors …
Genentech takes over Regor’s RGT-419B for US$850m upfront
Regor Enters into a Definitive Purchase Agreement for Genentech …
Genentech To Acquire Portfolio Of Next-generation CDK Inhibitors …
Regor Therapeutics Group
Regor Therapeutics Group
Regor Initiates Phase 2 Study of Oral Once-daily GLP-1 Agonist …
- Some results have been removed